Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

A Leading Innovative and Rare Disease Pharmaceutical Company

Medexus Pharmaceuticals, Inc. is a leading innovative and rare disease pharmaceutical company with a strong North American commercial platform. From a foundation of proven best in class products we are building a highly differentiated company with a portfolio of innovative and high value orphan and rare disease products that will underpin our growth for the next decade. 

About Us
Bringing Quality Healthcare Products to Market

Bringing Quality Healthcare Products to Market

For Patients and Healthcare Professionals

Our product portfolio features leading products that address a variety of diseases, including rheumatology, auto-immune disease, pediatrics, and specialty oncology

View Product Portfolio

Our Highly Scalable Business Platform

In addition to driving organic growth through sales of products within our existing portfolio, we are actively growing our product portfolio through new product launches, new product licensing and acquisitions.

Our Growth Strategy
Growing Product Pipeline

Growing Product Pipeline

We continuously look to license or acquire new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners, leveraging our North American sales force and infrastructure.

Licensing Targets

Canada

  • Rheumatology/Auto-immune disease
  • Hematology
  • Pediatrics
  • Allergy
  • Dermatology

USA

  • Rheumatology/Auto-immune disease
  • Hematology
Latest News

Latest News